How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Difficult to Manage AxSpA

RheumNow

D. Poddubnyy

EULAR® 2024 Insights - Factors Associated with the Evolution of Dege…

EULAR® 2024 Insights

L. Pina Vegas

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

Analysis of Gout Remission Definitions in a Randomized Controlled Tr…

The Journal of Rheumatology

E. Silverman, D. Tabi-Amponsah, N. Dalbeth

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Treating Gout or Hyperuricemia in CKD Patients

Abdul Abdellatif

Axial Spondyloarthritis: What Are the New Treatment Guidelines and B…

Marina Magrey

Hard Decisions: HSV and RSV Update for Rheumatology

RheumNow

K. Winthrop

Diagnosing Psoriatic Arthritis for the Dermatologist: Making a Diffe…

Masterclasses in Dermatology

J. Merola, A. Gottlieb

Gout Management Mistakes: Why Are Gout Patients Not Being Referred t…

RheumNow

J. Cush

EULAR 2023 Insights: The Role of Observational Data When Studying Sa…

EULAR 2023 Insights

A. Strangfeld

Treating to Target in Chronic Gout

Cleveland Clinic Rheumatology

P. Lipsky

Enthesitis & Dactylitis Management

RheumNow

A. Kavanaugh

Aims & Outcomes of Therapy in Ankylosing Spondylitis: What Are the A…

Keck School of Medicine of USC

N. Patel

Women in Rheumatology: Sex Differences in AxSpa

RheumNow

A. Ogdie

USSONAR Rheumatology Ultrasound Case Series Featuring Dr. Phil Chu

USSONAR

Inflammatory Arthritis: What Is It?

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Long COVID for the Rheumatologist

Cleveland Clinic Rheumatology

L. Calabrese

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan